Valuation (28%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.75 | N/A |
PEG Ratio (TTM) | 0.30 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 0.17 | N/A |
P/FCF Ratio (TTM) | -0.97 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -17.37% | N/A |
ROE (TTM) | -21.53% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -3.83% | -241.82% | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -4.03% | -156.53% | N/A |
Cash Flow | -10.37% | -254.98% | N/A |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 10.06 | N/A |
Quick Ratio (TTM) | 10.13 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |